Deepak Nitrite Limited Invests in Deepak Chem Tech Limited
Deepak Nitrite Limited (DNL) announced an investment in Deepak Chem Tech Limited (DCTL) on March 26, 2026. DCTL, a wholly owned subsidiary of DNL, issued and allotted 1,10,00,000 (1.1 million) 9% Optionally Convertible Redeemable Preference Shares (OCRPS) with a face value of ₹100 each, aggregating to ₹110 Crores to Deepak Phenolics Limited (DPL), another wholly owned subsidiary of the company. Additionally, DCTL allotted 25,00,000 (0.25 million) 9% OCRPS, also with a face value of ₹100 each, aggregating to ₹25 Crores to DNL.DCTL’s present paid-up capital, prior to the allotment, was ₹2099.50 Crores, comprising ₹499.50 Crores in equity shares and ₹1600 Crores in preference shares. The company currently operates plants for Fluorination, Nitric Acid, Nitration, and Hydrogenation and is pursuing projects across various sites in Gujarat. DCTL’s turnover for the fiscal year 2024-25 was ₹9.43 Crores.
The infusion of funds into DCTL by DPL and DNL is intended to strengthen the capital base of DCTL and support its project and general corporate expenses. The transaction between DCTL and DPL, and between DCTL and DNL, were completed on March 26, 2026, and were conducted at par.
According to details disclosed, DCTL and DPL are considered related parties under Indian Accounting Standards and the Companies Act, 2013. No governmental or regulatory approvals were required for the investment.
Prior to the allotment, Deepak Nitrite Limited held 100% of the equity share capital of DCTL and, along with DPL, indirectly held 100% of the preference share capital. Following the allotment, DNL continues to hold 100% of the equity share capital of DCTL and, along with DPL, indirectly holds 100% of the preference share capital.
Deepak Nitrite Limited is incorporated under CIN: 124110GJ1970P1C001735 and has its registered and corporate office at 2nd Floor, Fermenter House, Alembic city, Alembic Avenue Road, Vadodara - 390 003, Gujarat, India.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.